Development of Immune System Tolerance for the Treatment of Autoimmune Disease

Description:
The present invention provides a therapeutic method for the treatment of autoimmune or autoinflammatory diseases by first breaking down the dysregulated immune system and then reprogramming the immune system to restore tolerance to the patient's self-antigens by induction of antigen specific regulatory T cells. The inventors have shown that only with the combination of apoptosis, phagocytes, and antigen can antigen-specific regulatory T cells (Treg) cells be optimally generated to develop long-term immune tolerance. This strategy for developing immune tolerance can be applied to the treatment of autoimmune diseases.
Patent Information:
For Information, Contact:
Ediz Yonter
Senior Invention Development And Collaboration Specialist
NIH Technology Transfer
301-443-7494
ediz.yonter@nih.gov
Inventors:
Wanjun Chen
Keywords:
Alloantigen-specific
Apototic
CELL-MEDIATED
Cells
IB3XXX
IBXXXX
INDUCTION
IXXXXX
Patent Category - Biotechnology
Prevention
Regulatory
REJECTION
T
TRANSPLANT
© 2024. All Rights Reserved. Powered by Inteum